Identification de caractéristiques communes et rares dans les ARN structurés dans la base de données Rfam

Les ARN non codants (ARNnc) sont des transcrits d'ARN qui ne sont pas traduits en protéines et qui pourtant ont des fonctions clés et variées dans la cellule telles que la régulation des gènes, la transcription et la traduction. Parmi les nombreuses catégories d'ARNnc qui ont été découvertes, on trouve des ARN bien connus tels que les ARN ribosomiques (ARNr), les ARN de transfert (ARNt), les snoARN et les microARN (miARN). Les fonctions des ARNnc sont étroitement liées à leurs structures d’où l’importance de développer des outils de prédiction de structure et des méthodes de recherche de nouveaux ARNnc. Les progrès technologiques ont mis à la disposition des chercheurs des informations abondantes sur les séquences d'ARN. Ces informations sont accessibles dans des bases de données telles que Rfam, qui fournit des alignements et des informations structurelles sur de nombreuses familles d'ARNnc. Dans ce travail, nous avons récupéré toutes les séquences des structures secondaires annotées dans Rfam, telles que les boucles en épingle à cheveux, les boucles internes, les renflements « bulge », etc. dans toutes les familles d'ARNnc. Une base de données locale, RNAstem, a été créée pour faciliter la manipulation et la compilation des données sur les motifs de structure secondaire. Nous avons analysé toutes les boucles terminales et internes ainsi que les « bulges » et nous avons calculé un score d’abondance qui nous a permis d’étudier la fréquence de ces motifs. Tout en minimisant le biais de la surreprésentation de certaines classes d’ARN telles que l’ARN ribosomal, l’analyse des scores a permis de caractériser les motifs rares pour chacune des catégories d’ARN en plus de confirmer des motifs communs comme les boucles de type GNRA ou UNCG. Nous avons identifié des motifs abondants qui n’ont pas été étudiés auparavant tels que la « tetraloop » UUUU. En analysant le contenu de ces motifs en nucléotides, nous avons remarqué que ces régions simples brins contiennent beaucoup plus de nucléotides A et U. Enfin, nous avons exploré la possibilité d’utiliser ces scores pour la conception d’un filtre qui permettrait d’accélérer la recherche de nouveaux ARN non-codants. Nous avons développé un système de scores, RNAscore, qui permet d’évaluer un ARN en se basant sur son contenu en motifs et nous avons testé son applicabilité avec différents types de contrôles.

Artificial micro RNA system in Dictyostelium discoideum

Dictyostelium discoideum is a social amoeba that serves as a model system for RNA interference and related mechanisms. Its position between plants and animals enables evolutionary snapshot of mechanisms and protein machinery involved in investigated subjects. MiRNAs are small regulatory RNAs that are evolutionary conserved and present in animals, plants, viruses and some prokaryotes. They have roles in development, cell growth and differentiation, apoptosis and their miss-regulation is associated with many diseases such as cancer, neurodegenerative disorders and diabetes. Recently, through sequencing of DNA libraries miRNAs have been discovered in D. discoideum. In this work, it has been shown that heterologues miRNA let-7 can be expressed and processed in D. discoideum. Expression of let-7 miRNA in social amoeba resulted in a strong developmental phenotype suggesting an overload of the processing/silencing system or/and endogenous targets. The various effects on prel-7 strain have been observed and characterized, serving as a background for postulation of miRNA roles. An artificial miRNA system has been established and imposed to D. discoideum, showing that miRNAs in Dictyostelium could mediate gene expression on the level of mRNA stability and on the posttranscriptional level. Furthermore, presence of translational inhibition as a type of gene control was shown for the first time in this organism. Due to it new structures representing co-localities of miRNA and target mRNA have been detected. Taken together, this work shows functional artificial miRNA system and postulates roles of endogenous small RNA in social amoeba.

Molekularbiologische Charakterisierung der Argonauten Proteine AgnA und AgnB innerhalb der RNA vermittelten Genregulation in D. discoideum

Argonauten Proteine übernehmen vielfältige Funktionen in RNA vermittelten Signalwegen zur Genregulation und sind in eukaryotischen Organismen hoch konserviert. Obwohl das Repertoire an kleinen regulatorischen RNAs in D. discoideum schon früh untersucht wurde und dabei sowohl siRNAs als auch miRNAs identifiziert werden konnten, war die Funktion der fünf kodierten Argonauten Proteine zu Beginn meiner Arbeit noch völlig unbekannt. Im Fokus meiner Untersuchung standen die zwei Homologe AgnA und AgnB. Die molekularbiologische Charakterisierung von AgnA hat gezeigt, dass das Protein eine essentielle Funktion bei der posttranskriptionellen Regulation des Retrotransposons DIRS-1 hat. AgnA wird für die Generierung von über 90 % der DIRS-1 siRNAs benötigt, wobei unklar ist, ob die Slicer-Aktivität des Proteins relevant ist oder ob AgnA andere Proteine zur Generierung der kleinen RNAs rekrutiert. Mit Hilfe der Deep Sequencing Analyse kleiner RNAs im AgnA KO konnte die Abreicherung der DIRS-1 siRNAs bestätigt werden. Die Anreicherung von DIRS-1 sense und antisense Transkripten weist deutlich auf eine Deregulation des Retrotransposons bei Abwesenheit von AgnA hin. Der Verlust der AgnA abhängigen Regulationsebene ist nicht nur auf RNA- sondern auch auf DNA-Ebene nachweisbar, da im AgnA Knockout einzelsträngige extrachromosomale DIRS-1 Intermediate nachweisbar sind. Die Analyse dieser Strukturen mit Hilfe von Rasterkraftmikroskopie zeigt, dass die extrachromosomale DNA mit Proteinen assoziiert ist. Das Erscheinungsbild legt die Vermutung nahe, dass es sich um Virus ähnliche Partikel handeln könnte. Die Transposition der DIRS-1 Elemente konnte nicht nachgewiesen werden. Sie schlägt vermutlich fehl, da der zur Integration notwendige DNA-Doppelstrang nicht gebildet wird. Auch wenn der genaue Mechanismus der AgnA abhängigen DIRS-1 Regulation nicht vollständig aufgeklärt werden konnte, weisen die Ergebnisse darauf hin, dass AgnA nicht nur an der Biogenese der kleinen DIRS-1 siRNAs beteiligt ist, sondern auch weiter downstream, vermutlich innerhalb von Effektorkomplexen, als Regulator aktiv ist. AgnB ist nicht an der negativen Regulation des DIRS-1 Retrotransposons beteiligt. Im Gegenteil haben Experimente gezeigt, dass das Protein die Transkription des Elementes und die Bildung von DNA-Intermediaten eher positiv beeinflusst. Im Fall des Retrotransposons Skipper ist unklar, ob die wenigen siRNAs, die identifiziert worden sind, tatsächlich für die Regulation dieses Elementes genutzt werden. Der Knockout von AgnA hat eine Anreicherung der Skipper siRNAs zur Folge, wobei diese sehr variabel ist. Es konnten Skipper Transkripte nachgewiesen werden (Hinas et al., 2007), die wahrscheinlich die Vorläufermoleküle der siRNAs darstellen. Die Menge dieser Transkripte unterscheidet sich allerdings im Wildtyp und den untersuchten Knockout-Stämmen nicht. Bei der Untersuchung der miRNAs zeigte sich eine signifikante Anreicherung dieser regulatorischen RNAs im AgnA Knockout. Die Akkumulation kann durch die Expression von rekombinantem AgnA wieder auf Wildtyp Niveau gebracht werden. Die genaue Funktion von AgnA im miRNA Signalweg konnte aber nicht näher spezifiziert werden. Im Fall der beiden miRNAs konnte im Rahmen dieser Arbeit nachgewiesen werden, dass sie keine 2‘-O Methylierung besitzen und fast ausschließlich im Cytoplasma der Zelle vorliegen. Letzteres weist darauf hin, dass die untersuchten miRNAs ihre Zielgene vermutlich posttranskriptionell regulieren. Die Akkumulation von miRNAs im AgnA KO konnte ebenfalls durch Deep Sequencing Analysen verifiziert werden. Weiterhin wurden tRNA Fragmente gefunden, die im AgnA KO wesentlich stärker vertreten sind. Northern Blot Analysen haben gezeigt, dass ein zusätzliches Fragment der tRNA Asp akkumuliert, wenn AgnA nicht exprimiert wird. Möglicherweise ist AgnA am Umsatz der tRNA beteiligt. Die biologische Funktion der tRNA Fragmente in D. discoideum ist jedoch bisher ungeklärt. Bei der Suche nach putativen Interaktionspartnern konnte im Fall von AgnA das Protein DDB_G0268914 mittels Massenspektrometrie als putativer Interaktionspartner identifiziert werden. Dieses Protein zeigt Homologien zu MOV10 aus H. sapiens, das ebenfalls mit Argonauten Proteinen interagiert (Hock et al., 2007) und die Replikation von Retroviren unterdrückt (Burdick et al., 2010). Die Interaktion zwischen AgnA und dem MOV10 Homolog konnte bisher nicht mit anderen Ansätzen bestätigt werden. Darüber hinaus bleibt zu klären, ob der putative Interaktionsparter ebenfalls an der Regulation des Retrotransposons DIRS-1 beteiligt ist.

HelF und sein Interaktionspartner Xrn1: zwei Regulatoren der RNA-Interferenz in D. discoideum

Hauptziel dieser Arbeit ist die Identifizierung, Verifizierung und Charakterisierung von Interaktionspartnern von HelF, einem Negativregulator der RNA-Interferenz in Dictyostelium discoideum (Popova et al. 2006). Es ist gelungen, die Interaktion von HelF und der 5‘ 3‘ Exonuklease Xrn1 nachzu-weisen, aber alle anderen Versuchen, bisher unbekannte Protein-Interaktionspartner zu identifizieren, schlugen fehl. Xrn1 ist in den Organismen D. melanogaster (Orban und Izaurralde 2005), C. elegans (Newbury und Woollard 2004) und A. thaliana (Gazzani et al. 2004) bereits als Regulator der RNA-Interferenz bekannt. Mit Aufreinigungen nach der TAP-Methode und mit dem Nanotrap wurde ebenfalls versucht, RNA-Interaktionspartner von HelF zu identifizieren. Es konnten in einigen Aufreinigungen putative, für HelF spezifische RNAs identifiziert werden, doch entweder es handelte sich nachweislich nicht um RNA oder die Reproduktion der Daten schlug trotz mehrfacher Versuche fehl. Bezüglich der zellulären Lokalisation von HelF und Xrn1 konnte gezeigt werden, dass HelF zusätzlich zur bekannten Lokalisation in Foci im Nukleus (Popova et al. 2006) vermutlich auch im Cytoplasma und dort angeordnet in mehreren Granula zu finden ist. Xrn1 ist nahezu ausschließlich im Cytoplasma lokalisiert, wo es in mehreren Foci organisiert ist. Es wird vermutet, dass es sich bei diesen Foci um Processing-Bodies (P-Bodies) handelt und dass möglicherweise Xrn1 und HelF in eben diesen P-Bodies co-lokalisieren. In der Entwicklung vom Einzeller zum mehrzelligen Organismus zeigen die Xrn1KO- und die HelFKO-Mutante jeweils einen eindeutigen Phänotyp, der vom Wildtyp abweicht. Die Phänotypen der beiden Mutanten unterscheiden sich deutlich voneinander. Beim Mischen von HelF-Knockout-Zellen mit grün fluoreszierenden Wildtyp-Zellen zeigt sich, dass beide Stämme innerhalb des sich entwickelnden Organismus an definierten Stellen lokalisieren. Entgegen den Erwartungen befinden sich die Zellen der Mutante in den Stadien „Finger“ und „Slug“ nicht hauptsächlich im vorderen Teil des Organismus, sondern sind auch im hinteren Teil, der später die Sporenmasse bildet, vertreten. Dies lässt vermuten, dass HelF-Knockout-Mutanten in gleichem Maße wie Wildtypzellen als Sporen in die nächste Generation übergehen. Weitere Mix-Experimente, in denen HelFKO-Zellen und Xrn1KO-Zellen mit grün fluoreszierenden Wildtypzellen gemischt wurden, belegen eindeutig, dass beide Knockoutmutanten in Konkurrenz zum Wildtyp bei der Generierung von Sporen und somit beim Übergang in die nächste Generation benachteiligt sind. Dies steht im Gegensatz zu den Ergebnissen der vorher beschriebenen Mix-Experimente, in denen der Organismus als Ganzes betrachtet wurde. Weiterhin konnte herausgefunden werden, dass Xrn1 ebenso wie HelF (Popova et al. 2006) eine Rolle als Negativregulator in der RNA-Interferenz innehat. Fraglich ist aber, ob HelF wie bisher angenommen auch Einfluss auf den Weg der Generierung von miRNAs nimmt, da in HelFKO für keinen der beiden miRNA-Kandidaten eine Hoch- bzw. Runterregulierung der reifen miRNAs im Vergleich zum Wildtyp beobachtet werden kann. Im Xrn1KO hingegen ist die reife miRNA ddi-mir-1176 im Vergleich zum Wildtyp hochreguliert. In Bezug auf die Generierung von siRNAs konnte herausgefunden werden, dass Xrn1 und HelF im Fall der Generierung von Skipper siRNAs regulierend eingreifen, dass aber nicht alle siRNAs von der negativen Regulierung durch HelF und Xrn1betroffen sind, was am Beispiel der DIRS-1-siRNAs belegt werden kann. Das von B. Popova entwickelte Modell (Popova 2005) bezüglich der Rolle von HelF in der RNA-Interferenz wurde basierend auf den neu gewonnenen Daten weiterentwickelt und um Xrn1 ergänzt, um die Funktionen von HelF und Xrn1 als Antagonisten der RNA-Interferenz näher zu beleuchten. Literatur: Gazzani, S., T. Lawrenson, et al. (2004). "A link between mRNA turnover and RNA interference in Arabidopsis." Science 306(5698): 1046-8. Newbury, S. and A. Woollard (2004). "The 5'-3' exoribonuclease xrn-1 is essential for ventral epithelial enclosure during C. elegans embryogenesis." Rna 10(1): 59-65. Orban, T. I. and E. Izaurralde (2005). "Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome." Rna 11(4): 459-69. Popova, B. (2005). HelF, a suppressor of RNAi mediated gene silencing in Dictyostelium discoideum. Genetik. Kassel, Universität Kassel. PhD: 200. Popova, B., M. Kuhlmann, et al. (2006). "HelF, a putative RNA helicase acts as a nuclear suppressor of RNAi but not antisense mediated gene silencing." Nucleic Acids Res 34(3): 773-84.

Genome sequences of the human body louse and its primary endosymbiont provide insights into the permanent parasitic lifestyle

As an obligatory parasite of humans, the body louse (Pediculus humanus humanus) is an important vector for human diseases, including epidemic typhus, relapsing fever, and trench fever. Here, we present genome sequences of the body louse and its primary bacterial endosymbiont Candidatus Riesia pediculicola. The body louse has the smallest known insect genome, spanning 108 Mb. Despite its status as an obligate parasite, it retains a remarkably complete basal insect repertoire of 10,773 protein-coding genes and 57 microRNAs. Representing hemimetabolous insects, the genome of the body louse thus provides a reference for studies of holometabolous insects. Compared with other insect genomes, the body louse genome contains significantly fewer genes associated with environmental sensing and response, including odorant and gustatory receptors and detoxifying enzymes. The unique architecture of the 18 minicircular mitochondrial chromosomes of the body louse may be linked to the loss of the gene encoding the mitochondrial single-stranded DNA binding protein. The genome of the obligatory louse endosymbiont Candidatus Riesia pediculicola encodes less than 600 genes on a short, linear chromosome and a circular plasmid. The plasmid harbors a unique arrangement of genes required for the synthesis of pantothenate, an essential vitamin deficient in the louse diet. The human body louse, its primary endosymbiont, and the bacterial pathogens that it vectors all possess genomes reduced in size compared with their free-living close relatives. Thus, the body louse genome project offers unique information and tools to use in advancing understanding of coevolution among vectors, symbionts, and pathogens.

The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease

Huntington's disease (HD) is a devastating disorder that affects approximately 1 in 10,000 people and is accompanied by neuronal dysfunction and neurodegeneration. HD manifests as a progressive chorea, a decline in mental abilities accompanied by behavioural, emotional and psychiatric problems followed by, dementia, and ultimately, death. The molecular pathology of HD is complex but includes widespread transcriptional dysregulation. Although many transcriptional regulatory molecules have been implicated in the pathogenesis of HD, a growing body of evidence points to the pivotal role of RE1 Silencing Transcription Factor (REST). In HD, REST, translocates from the cytoplasm to the nucleus in neurons resulting in repression of key target genes such as BDNF. Since these original observations, several thousand direct target genes of REST have been identified, including numerous non-coding RNAs including both microRNAs and long non-coding RNAs, several of which are dysregulated in HD. More recently, evidence is emerging that hints at epigenetic abnormalities in HD brain. This in turn, promotes the notion that targeting the epigenetic machinery may be a useful strategy for treatment of some aspects of HD. REST also recruits a host of histone and chromatin modifying activities that can regulate the local epigenetic signature at REST target genes. Collectively, these observations present REST as a hub that coordinates transcriptional, posttranscriptional and epigenetic programmes, many of which are disrupted in HD. We identify several spokes emanating from this REST hub that may represent useful sites to redress REST dysfunction in HD.

Molecular archaeology of Flaviviridae untranslated regions: duplicated RNA structures in the replication enhancer of flaviviruses and pestiviruses emerged via convergent evolution.

RNA secondary structures in the 3'untranslated regions (3'UTR) of the viruses of the family Flaviviridae, previously identified as essential (promoters) or beneficial (enhancers) for replication, have been analysed. Duplicated enhancer elements are revealed as a global feature in the evolution of the 3'UTR of distantly related viruses within the genera Flavivirus and Pestivirus. For the flaviviruses, duplicated structures occur in the 3'UTR of all four distantly related ecological virus subgroups (tick-borne, mosquito-borne, no known vector and insect-specific flaviviruses (ISFV). RNA structural differences distinguish tick-borne flaviviruses with discrete pathogenetic characteristics. For Aedes- and Culex-associated ISFV, secondary RNA structures with different conformations display numerous short ssRNA direct repeats, exposed as loops and bulges. Long quadruplicate regions comprise almost the entire 3'UTR of Culex-associated ISFV. Extended duplicated sequence and associated RNA structures were also discovered in the 3'UTR of pestiviruses. In both the Flavivirus and Pestivirus genera, duplicated RNA structures were localized to the enhancer regions of the 3'UTR suggesting an adaptive role predominantly in wild-type viruses. We propose sequence reiteration might act as a scaffold for dimerization of proteins involved in assembly of viral replicase complexes. Numerous nucleotide repeats exposed as loops/bulges might also interfere with host immune responses acting as a molecular sponge to sequester key host proteins or microRNAs.

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators

Nucleotide-based drug candidates such as antisense oligonucleotides, aptamers, immunoreceptor-activating nucleotides, or (anti)microRNAs hold great therapeutic promise for many human diseases. Phosphorothioate (PS) backbone modification of nucleotide-based drugs is common practice to protect these promising drug candidates from rapid degradation by plasma and intracellular nucleases. Effects of the changes in physicochemical properties associated with PS modification on platelets have not been elucidated so far. Here we report the unexpected binding of PS-modified oligonucleotides to platelets eliciting strong platelet activation, signaling, reactive oxygen species generation, adhesion, spreading, aggregation, and thrombus formation in vitro and in vivo. Mechanistically, the platelet-specific receptor glycoprotein VI (GPVI) mediates these platelet-activating effects. Notably, platelets from GPVI function-deficient patients do not exhibit binding of PS-modified oligonucleotides, and platelet activation is fully abolished. Our data demonstrate a novel, unexpected, PS backbone-dependent, platelet-activating effect of nucleotide-based drug candidates mediated by GPVI. This unforeseen effect should be considered in the ongoing development programs for the broad range of upcoming and promising DNA/RNA therapeutics.

MiR-375 is essential for human spinal motor neuron development and may be involved in motor neuron degeneration

The transcription factor REST is a key suppressor of neuronal genes in non-neuronal tissues. REST has been shown to suppress pro-neuronal microRNAs in neural progenitors indicating that REST-mediated neurogenic suppression may act in part via microRNAs. We used neural differentiation of Rest-null mouse ESC to identify dozens of microRNAs regulated by REST during neural development. One of the identified microRNAs, miR-375, was upregulated during human spinal motor neuron development. We found that miR-375 facilitates spinal motor neurogenesis by targeting the cyclin kinase CCND2 and the transcription factor PAX6. Additionally, miR-375 inhibits the tumor suppressor p53 and protects neurons from apoptosis in response to DNA damage. Interestingly, motor neurons derived from a spinal muscular atrophy patient displayed depressed miR-375 expression and elevated p53 protein levels. Importantly, SMA motor neurons were significantly more susceptible to DNA damage induced apoptosis suggesting that miR-375 may play a protective role in motor neurons.

MEF2C-MYOCD and leiomodin1 suppression by miRNA-214 promotes smooth muscle cell phenotype switching in pulmonary arterial hypertension

Background Vascular hyperproliferative disorders are characterized by excessive smooth muscle cell (SMC) proliferation leading to vessel remodeling and occlusion. In pulmonary arterial hypertension (PAH), SMC phenotype switching from a terminally differentiated contractile to synthetic state is gaining traction as our understanding of the disease progression improves. While maintenance of SMC contractile phenotype is reportedly orchestrated by a MEF2C-myocardin (MYOCD) interplay, little is known regarding molecular control at this nexus. Moreover, the burgeoning interest in microRNAs (miRs) provides the basis for exploring their modulation of MEF2C-MYOCD signaling, and in turn, a pro-proliferative, synthetic SMC phenotype. We hypothesized that suppression of SMC contractile phenotype in pulmonary hypertension is mediated by miR-214 via repression of the MEF2C-MYOCD-leiomodin1 (LMOD1) signaling axis. Methods and Results In SMCs isolated from a PAH patient cohort and commercially obtained hPASMCs exposed to hypoxia, miR-214 expression was monitored by qRT-PCR. miR-214 was upregulated in PAH- vs. control subject hPASMCs as well as in commercially obtained hPASMCs exposed to hypoxia. These increases in miR-214 were paralleled by MEF2C, MYOCD and SMC contractile protein downregulation. Of these, LMOD1 and MEF2C were directly targeted by the miR. Mir-214 overexpression mimicked the PAH profile, downregulating MEF2C and LMOD1. AntagomiR-214 abrogated hypoxia-induced suppression of the contractile phenotype and its attendant proliferation. Anti-miR-214 also restored PAH-PASMCs to a contractile phenotype seen during vascular homeostasis. Conclusions Our findings illustrate a key role for miR-214 in modulation of MEF2C-MYOCD-LMOD1 signaling and suggest that an antagonist of miR-214 could mitigate SMC phenotype changes and proliferation in vascular hyperproliferative disorders including PAH.

Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers

Facioscapulohumeral muscular dystrophy (FSHD) is a progressive muscle disorder that has been associated with a contraction of 3.3-kb repeats on chromosome 4q35. FSHD is characterized by a wide clinical inter- and intrafamilial variability, ranging from wheelchair-bound patients to asymptomatic carriers. Our study is unique in comparing the gene expression profiles from related affected, asymptomatic carrier, and control individuals. Our results suggest that the expression of genes on chromosome 4q is altered in affected and asymptomatic individuals. Remarkably, the changes seen in asymptomatic samples are largely in products of genes encoding several chemokines, whereas the changes seen in affected samples are largely in genes governing the synthesis of GPI-linked proteins and histone acetylation. Besides this, the affected patient and related asymptomatic carrier share the 4qA161 haplotype. Thus, these polymorphisms by themselves do not explain the pathogenicity of the contracted allele. Interestingly, our results also suggest that the miRNAs might mediate the regulatory network in FSHD. Together, our results support the previous evidence that FSHD may be caused by transcriptional dysregulation of multiple genes, in cis and in trans, and suggest some factors potentially important for FSHD pathogenesis. The study of the gene expression profiles from asymptomatic carriers and related affected patients is a unique approach to try to enhance our understanding of the missing link between the contraction in D4Z4 repeats and muscle disease, while minimizing the effects of differences resulting from genetic background.

Conserved tissue expression signatures of intronic noncoding RNAs transcribed from human and mouse loci

It has been postulated that noncoding RNAs (ncRNAs) are involved in the posttranscriptional control of gene expression, and may have contributed to the emergence of the complex attributes observed in mammalians. We show here that the complement of ncRNAs expressed from intronic regions of the human and mouse genomes comprises at least 78,147 and 39,660 transcriptional units, respectively. To identify conserved intronic sequences expressed in both humans and mice, we used custom-designed human cDNA microarrays to separately interrogate RNA from mouse and human liver, kidney, and prostate tissues. An overlapping tissue expression signature was detected for both species, comprising 198 transcripts; among these, 22 RNAs map to intronic regions with evidence of evolutionary conservation in humans and mice. Transcription of selected human-mouse intronic ncRNAs was confirmed using strand-specific RT-PCR. Altogether, these results support an evolutionarily conserved role of intronic ncRNAs in human and mouse, which are likely to be involved in the fine tuning of gene expression regulation in different mammalian tissues. (C) 2008 Elsevier Inc. All rights reserved.

MicroRNA-100 Acts as a Tumor Suppressor in Human Bladder Carcinoma 5637 Cells

Bladder carcinoma is one of the most common tumors in the world and, despite the therapy currently available, most of the patients relapse. Better understanding of the factors involved in disease pathogenesis would provide insights for the development of more effective strategies in treatment. Recently, differential miRNA expression profiles in bladder urothelial carcinomas identified miR-100 down-regulation and miR-708 up-regulation among the most common alterations, although the possible influence of these miRNAs in the control of basic mechanisms in bladder tumors has not been addressed. In this context, the present study aimed to evaluate the in vitro effects of miR-100 forced expression and miR-708 inhibition in the bladder carcinoma cell line 5637. Our results showed that overexpression of miR-100 significantly inhibited growth when compared to controls at both times tested (72 and 96 hours, p<0.01) with a maximum effect at 72 hours reducing proliferation in 29.6 %. Conversely, no effects on cell growth were observed after inhibition of miR-708. MiR-100 also reduced colony formation capacity of 5637 cells by 24.4%. No alterations in cell cycle progression or apoptosis induction were observed. The effects of miR-100 on growth and clonogenicity capacity in 5637 cells evince a possible role of this miRNA in bladder carcinoma pathogenesis. Further studies are necessary to corroborate our findings and examine the potential use of this microRNA in future therapeutic interventions.

Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma

MicroRNAs (miRs) are non-coding RNA molecules involved in cancer initiation and progression. Deregulated miR expression has been implicated in cancer; however, there are no studies implicating an miR signature associated with progression in oral squamous cell carcinoma (OSCC). Although OSCC may develop from oral leukoplakia, clinical and histological assessments have limited prognostic value in predicting which leukoplakic lesions will progress. Our aim was to quantify miR expression changes in leukoplakia and same-site OSCC and to identify an miR signature associated with progression. We examined miR expression changes in 43 sequential progressive samples from 12 patients and four non-progressive leukoplakias from four different patients, using TaqMan Low Density Arrays. The findings were validated using quantitative RT-PCR in an independent cohort of 52 progressive dysplasias and OSCCs, and five non-progressive dysplasias. Global miR expression profiles distinguished progressive leukoplakia/OSCC from non-progressive leukoplakias/normal tissues. One hundred and nine miRs were highly expressed exclusively in progressive leukoplakia and invasive OSCC. miR-21, miR-181b and miR-345 expressions were consistently increased and associated with increases in lesion severity during progression. Over-expression of miR-21, miR-181b and miR-345 may play an important role in malignant transformation. Our study provides the first evidence of an miR signature potentially useful for identifying leukoplakias at risk of malignant transformation.

An Integrative Genomic and Transcriptomic Analysis Reveals Potential Targets Associated with Cell Proliferation in Uterine Leiomyomas

Background: Uterine Leiomyomas (ULs) are the most common benign tumours affecting women of reproductive age. ULs represent a major problem in public health, as they are the main indication for hysterectomy. Approximately 40-50% of ULs have non-random cytogenetic abnormalities, and half of ULs may have copy number alterations (CNAs). Gene expression microarrays studies have demonstrated that cell proliferation genes act in response to growth factors and steroids. However, only a few genes mapping to CNAs regions were found to be associated with ULs. Methodology: We applied an integrative analysis using genomic and transcriptomic data to identify the pathways and molecular markers associated with ULs. Fifty-one fresh frozen specimens were evaluated by array CGH (JISTIC) and gene expression microarrays (SAM). The CONEXIC algorithm was applied to integrate the data. Principal Findings: The integrated analysis identified the top 30 significant genes (P<0.01), which comprised genes associated with cancer, whereas the protein-protein interaction analysis indicated a strong association between FANCA and BRCA1. Functional in silico analysis revealed target molecules for drugs involved in cell proliferation, including FGFR1 and IGFBP5. Transcriptional and protein analyses showed that FGFR1 (P = 0.006 and P<0.01, respectively) and IGFBP5 (P = 0.0002 and P = 0.006, respectively) were up-regulated in the tumours when compared with the adjacent normal myometrium. Conclusions: The integrative genomic and transcriptomic approach indicated that FGFR1 and IGFBP5 amplification, as well as the consequent up-regulation of the protein products, plays an important role in the aetiology of ULs and thus provides data for potential drug therapies development to target genes associated with cellular proliferation in ULs. © 2013 Cirilo et al.